(SNCA) |
| 0 (0%) 10-18 15:32 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Sun, 11 Oct 2026
SNCA Bond Profile: Coupon and Redemption - TradingView
Thu, 27 Aug 2026
Reduced SNCA gene expression is associated with Alzheimer's disease in postmortem brain tissue - ScienceDirect.com
Thu, 06 Aug 2026
α-Synuclein blocks endoplasmic reticulum co-translational protein translocation early in Parkinson’s disease - Nature
Mon, 13 Jul 2026
α-Synuclein burden amplification in Parkinson’s disease: a unified genetic, molecular, and cellular framework - Frontiers
Fri, 19 Jun 2026
Altered light-dark phase-dependent behavioral responses and suprachiasmatic nucleus pathology in an α -synuclein rat model of Parkinson’s disease - Nature
Mon, 27 Apr 2026
Noncoding variation and regulatory control of SNCA in Lewy body dementia - npj Dementia - Nature
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
